Hims Semaglutide — What It Is and How It Works
Hims is one of the largest direct-to-consumer telehealth platforms in the US. Their compounded semaglutide program is legitimate — licensed clinicians, 503A compounding pharmacy, state-compliant prescribing. Their starting dose price (~$149/month) is below Luma Health's $197/month flat. As doses increase through titration, Hims' price escalates to $199/month or more at maintenance — converging with or exceeding Luma Health's flat rate. The documented pattern complaints (cancellation friction, pharmacy non-disclosure, no video consultations for GLP-1) are service model limitations, not safety concerns.
Semaglutide Clinical Evidence: The Same Molecule at Both Platforms
Hims Semaglutide Price vs Luma Health — Through the Full Titration Timeline
Starting Dose vs Maintenance: Where Each Platform Wins on Price
The price crossover happens around months 5–8 of a typical titration schedule. Hims is genuinely less expensive at starting doses. Luma Health is less expensive or equal at maintenance. The annual totals are close — Hims' range of $2,028–$2,388 overlaps with Luma Health's $2,364 flat depending on how quickly you reach maintenance dose. The flat-rate advantage of Luma Health: you know exactly what you'll pay every month, permanently, without tracking dose-tier changes.
Hims Semaglutide: Documented Gaps vs Stronger Telehealth Platforms
Pharmacy not named for independent verification
Hims does not prominently disclose the specific compounding pharmacy preparing their semaglutide in consumer-facing materials. Patients cannot independently verify the pharmacy's state board license before enrolling. Contact Hims support and ask for the pharmacy's name and license number — this information should be available on request for any patient asking about their injectable medication supply chain.
Maintenance pricing surprise — dose-tier increases not always disclosed upfront
Hims' starting dose price (~$149/mo) is frequently promoted. The maintenance dose price (~$199/mo+) is less prominently communicated during enrollment. Patients who enroll expecting to pay $149/month permanently are surprised when their bill increases as dose escalates. Ask Hims specifically: "What is my monthly rate at the 2.4 mg/week maintenance dose?" before providing payment.
No video consultations for GLP-1 weight loss
Hims' GLP-1 weight loss program is async-only — text and messaging communication with providers, no video consultations. For patients who want face-to-face clinical interaction for dose adjustments, side effect management, or clinical questions, Hims' async model is a limitation. Ro Body (Plus/Premium plans) and Calibrate both offer video consultations for GLP-1 patients.
Cancellation friction is a documented patient complaint
Hims cancellation has recurring patient complaints — charges continuing after cancellation, difficulty completing the process. If you enroll with Hims, screenshot your cancellation confirmation immediately, request written email confirmation with the effective date, and monitor your payment method for two additional billing cycles after cancellation. See our Hims complaints guide for the full documented pattern.
Hims vs Luma Health: Full Semaglutide Comparison
| Factor | Hims | Luma Health |
|---|---|---|
| Starting dose sema | ~$149/mo ✓ | $197/mo flat |
| Maintenance dose sema | ~$199/mo+ ✗ | $197/mo flat ✓ |
| Pricing model | Dose-tier (increases with dose) | Flat — same price all doses |
| Pharmacy named publicly | Not prominently | ✓ VialsRX TX#35264 |
| Video consultations | Not offered for GLP-1 | Not offered |
| Tirzepatide | ~$249–$329/mo (limited access) | ✓ $297/mo flat |
| Cancellation | Friction documented — document carefully | Cancel anytime — single subscription |
| Annual total (avg) | ~$2,028–$2,388 | $2,364 flat |
| Insurance (compounded) | No — cash-pay only | No — cash-pay only |
| FSA/HSA eligible | ✓ Typically yes | ✓ Typically yes |
| Clinical entity | Hims Medical Group | Wasef Health, PC |
Hims vs the Broader Telehealth Semaglutide Market
| Provider | Sema (starting) | Sema (maintenance) | Annual (~) | Pharmacy Named | Cancel Anytime |
|---|---|---|---|---|---|
| Henry Meds | ~$89–$145/mo | ~$145/mo flat | ~$1,740/yr | No | Annual required |
| Hims | ~$149/mo | ~$199/mo+ | ~$2,028–$2,388 | No | Yes (friction) |
| ★ Luma Health | $197/mo flat | $197/mo flat | $2,364/yr flat | ✓ VialsRX TX#35264 | ✓ No commitment |
| Ro Body | ~$145–$169/mo | ~$199–$229/mo | ~$2,148–$2,748 | Ro-owned | Yes |
| Found | ~$129/mo | ~$179–$199/mo | ~$1,548–$2,388 | No | Yes |
Frequently Asked Questions
Is Hims cheaper than Luma Health for semaglutide?
At starting doses (0.25–0.5 mg/week), yes — Hims' ~$149/month is less than Luma Health's $197/month flat. At maintenance doses (1.7–2.4 mg/week), no — Hims' ~$199/month or more exceeds Luma Health's flat $197/month. Over a typical 12-month treatment course mixing starting and maintenance doses, the annual totals are comparable: Hims approximately $2,028–$2,388 vs Luma Health $2,364 flat. For patients who remain at lower doses, Hims is less expensive. For patients who reach maintenance doses (the majority who continue long-term), Luma Health is comparable or less expensive — with the added benefit of predictability.
Why doesn't Hims name its compounding pharmacy?
Hims has not prominently disclosed the specific 503A compounding pharmacy preparing their semaglutide in consumer-facing materials as of June 2026. The reason is likely competitive — pharmacy partnerships are proprietary business relationships. The consequence for patients: you cannot independently verify the pharmacy's state board license at pharmacy.texas.gov or equivalent before committing to weekly injections from that source. Contact Hims support directly and ask: "What is the name and state board license number of the compounding pharmacy that prepares my semaglutide?" This is a reasonable request they should be able to answer.
How does Hims compare to Ro Body for semaglutide?
Both Hims and Ro offer dose-tier compounded semaglutide at similar price ranges. Ro's starting price (~$145/mo) is marginally lower than Hims' (~$149/mo). Both reach maintenance pricing around $199/month or more. Ro has three meaningful advantages over Hims for semaglutide: Ro navigates brand-name Wegovy through insurance (which Hims doesn't offer), Ro names their own pharmacy ("Ro Pharmacy"), and Ro offers video consultations on Plus/Premium plans. For patients considering Hims vs Ro specifically, Ro is generally the stronger option due to insurance navigation capability and video consultation access. See our Hims vs Ro comparison for the full breakdown.
Does Hims offer tirzepatide as well as semaglutide?
Hims offers tirzepatide, but access is more limited than semaglutide — availability varies by state and patient profile. Hims' tirzepatide is dose-tier priced at approximately $249–$329/month depending on dose. For patients who want predictable flat-rate tirzepatide access, Luma Health ($297/month flat) and Henry Meds (~$179/month annual) are more straightforward options. For patients prioritizing semaglutide specifically, Hims' starting price advantage applies to semaglutide only.
What are the most common Hims semaglutide complaints?
The four most documented patient complaints about Hims' semaglutide program: (1) Maintenance pricing surprise — the dose-tier increase to $199/month at higher doses is not always prominently communicated during enrollment; (2) Pharmacy not disclosed — patients can't independently verify the compounding pharmacy's credentials; (3) No video consultations for GLP-1 — the async-only model frustrates patients who need more clinical interaction; (4) Cancellation friction — documented pattern of charges continuing after cancellation, difficulty getting written confirmation. See our detailed Hims complaints guide for the full breakdown and which issues are Hims-specific vs industry-wide.
Can I switch from Hims to Luma Health without restarting my semaglutide dose?
Yes. Start Luma Health's intake at start.mylumahealth.com with your current semaglutide dose while you have 2–3 weeks of Hims medication remaining. Wasef Health, PC prescribes at your current dose — no re-titration. Wait for VialsRX shipping confirmation before initiating Hims cancellation. When canceling Hims, screenshot the confirmation screen immediately and request written email confirmation with the effective cancellation date — this protects against the documented continued-billing issue. Continue your current dose from the VialsRX vial on your next injection day.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28:2083–2091. PubMed
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221–2232. PubMed
- Perkovic V, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). N Engl J Med. 2024;391(2):109–121. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
- Hims. Weight Loss Program. hims.com